Mion、Witsch等[18,19]用13C-酮戊异酸呼气试验测定酒精性脂肪性肝炎（alcoholic steatohepatitis，ASH）、非酒精性脂肪性肝炎（non- alcoholic steatohepatitis，NASH）的肝细...
基于8个网页-相关网页
...非酒精性脂肪性肝炎的临床病理研究 NASH)的临床和病理学特征。方法：对40例NASH患者的临床资料和穿刺肝组织进行临床和病理学分析，并与酒精性脂肪性肝炎（Alcoholic stea...
基于2个网页-相关网页
非酒精性脂肪性肝炎 NASH ; nonalcoholic steatohepatitis ; nonalcoholic ; Non-alcoholic fatty hepatitis
为非酒精性脂肪性肝炎 Nonalcoholic steatohepatitis
和非酒精性脂肪性肝炎 Nonalcoholic steato-hepatitis
了非酒精性脂肪性肝炎 nonalcoholic steatohepatitis
测定酒精性脂肪性肝炎 alcoholic steatohepatitis ; ASH
在非酒精性脂肪性肝炎 nonalcoholic steatohepatitis
的非酒精性脂肪性肝炎 nonalcoholic steatohepatitis
和酒精性脂肪性肝炎 alcoholicsteatohepatitis
与酒精性脂肪性肝炎 Alcoholic steatohepatitis
联合治疗应是未来非酒精性脂肪性肝炎临床试验的范例吗？
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
此外，肝脏基金会估计有5%的美国人患非酒精性脂肪性肝炎。
Additionally, the liver foundation estimates that about 5 percent of Americans have NASH.
我们必须认识到所有非酒精性脂肪性肝炎患者发病机制并不是单一的信号途径。
I think that it probably has to do with the fact that the pathogenesis of all patients with non-alcoholic steatohepatitis, is probably not a single way or a single pathway.
应用推荐